Dauch
DCH
5.79
-0.06
-1.03%
Dauch
US · DCH
#3068 by market cap
Listed 1970
5.79
-0.06
-1.03%
Live - 5344 symbols - heartbeat 139s ago
· 2026-10-08 07:58
Pre-market
5.79
0.00%
After-hours
5.82
+0.52%
Overnight
5.76
-0.52%
- Market cap
- 1.38B
- P/E (TTM)i
- -5.73
- P/Bi
- 0.91
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on DCH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.50, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -4.71% YoY
Margins
- Gross margin
- 12.07%
- Operating margin
- 4.00%
- Net margin
- -0.34%
Key ratios & quality
- Enterprise valuei
- 4.74B
- Altman Z-Scorei
- 1.50
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.27B | 6.53B | 4.71B | 5.16B | 5.80B | 6.08B | 6.12B | 5.84B |
| Gross profit | 1.14B | 902.60M | 582.70M | 722.70M | 704.90M | 624.30M | 741.40M | 704.50M |
| Selling & admin expenses | 385.70M | 364.70M | 313.90M | 344.20M | 345.10M | 366.90M | 387.10M | 389.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 655.30M | 442.50M | 182.20M | 292.70M | 274.10M | 171.80M | 271.40M | 233.70M |
| Pretax profit | -113.90M | -533.00M | -610.30M | 1.20M | 66.30M | -24.50M | 62.80M | 1.50M |
| Tax | -57.10M | -48.90M | -49.20M | -4.70M | 2.00M | 9.10M | 27.80M | 21.20M |
| Net profit | -56.80M | -484.10M | -561.10M | 5.90M | 64.30M | -33.60M | 35.00M | -19.70M |
| Basic EPS | -1 | -4 | -5 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | -0.51 | -4.31 | -4.96 | 0.05 | 0.53 | -0.29 | 0.29 | -0.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.41B | 1.54B | 1.51B | 1.38B | 2.38B | 2.96B |
| Gross profit | 173.90M | 200.70M | 189.00M | 140.90M | 225.40M | 338.20M |
| Selling & admin expenses | 90.90M | 100.80M | 98.80M | 98.50M | 137.30M | 166.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 62.40M | 79.50M | 69.80M | 22.00M | 65.20M | 149.50M |
| Pretax profit | 21.10M | 67.40M | -1.70M | -85.30M | -119.60M | 17.60M |
| Tax | 14.00M | 28.10M | -10.90M | -10.00M | -19.60M | 16.10M |
| Net profit | 7.10M | 39.30M | 9.20M | -75.30M | -100.00M | 1.50M |
| Basic EPS | 0 | 0 | 0 | -1 | -1 | 0 |
| Diluted EPS | 0.06 | 0.32 | 0.07 | -0.63 | -0.52 | 0.00 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.03B | 1.86B | 1.88B | 1.86B | 1.99B | 2.01B | 1.91B | 3.64B |
| Cash & ST investments | 476.40M | 532.00M | 557.00M | 530.20M | 511.50M | 519.90M | 552.90M | 708.90M |
| Inventory | 459.70M | 373.60M | 323.20M | 410.40M | 463.90M | 482.90M | 442.50M | 466.40M |
| Total assets | 7.51B | 6.64B | 5.92B | 5.64B | 5.47B | 5.36B | 5.06B | 6.67B |
| Total current liabilities | 1.36B | 1.03B | 979.30M | 1.04B | 1.20B | 1.20B | 1.18B | 1.23B |
| Short-term debt | 121.60M | 50.50M | 36.30M | 43.40M | 97.00M | 38.90M | 70.70M | 35.10M |
| Long-term debt | 3.69B | 3.61B | 3.44B | 3.09B | 2.85B | 2.75B | 2.58B | 4.04B |
| Total liabilities | 6,024,400,000.00 | 5,664,200,000.00 | 5,543,100,000.00 | 5,177,900,000.00 | 4,842,100,000.00 | 4,751,400,000.00 | 4,497,100,000.00 | 6,030,200,000.00 |
| Total equity | 1.49B | 980.40M | 373.20M | 457.80M | 627.30M | 604.90M | 562.80M | 640.00M |
| Retained earnings | 703.50M | 248.60M | -319.80M | -313.90M | -249.60M | -283.20M | -248.20M | -267.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.03B | 2.17B | 2.25B | 3.64B | 3.89B | 3.73B |
| Cash & ST investments | 549.20M | 586.50M | 714.10M | 708.90M | 1.01B | 880.80M |
| Inventory | 434.30M | 449.10M | 442.40M | 466.40M | 1.00B | 1.00B |
| Total assets | 5.14B | 5.27B | 5.34B | 6.67B | 11.27B | 11.05B |
| Total current liabilities | 1.18B | 1.23B | 1.27B | 1.23B | 2.79B | 2.67B |
| Short-term debt | 34.60M | 44.90M | 44.60M | 35.10M | 39.70M | 37.60M |
| Long-term debt | 2.61B | 2.60B | 2.59B | 4.04B | 5.16B | 5.03B |
| Total liabilities | 4,543,100,000.00 | 4,600,600,000.00 | 4,624,800,000.00 | 6,030,200,000.00 | 9,768,500,000.00 | 9,534,500,000.00 |
| Total equity | 596.30M | 673.00M | 718.40M | 640.00M | 1.50B | 1.52B |
| Retained earnings | -241.10M | -201.80M | -192.60M | -267.90M | -368.20M | -367.20M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 771.50M | 559.60M | 454.70M | 538.40M | 448.90M | 396.10M | 455.40M | 411.60M |
| Depreciation & amortization | 528.80M | 536.90M | 521.90M | 544.30M | 492.10M | 487.20M | 469.70M | 459.50M |
| Free cash flow | 246.30M | 125.40M | 239.00M | 357.20M | 273.50M | 199.40M | 204.30M | 149.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -3.70M | -7.50M | -2.70M | -4.30M | -1.90M | -14.70M | -2.80M | -2.80M |
| Ending cash balance | 478.90M | 532.00M | 557.00M | 530.20M | 511.50M | 519.90M | 552.90M | 2.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 55.90M | 91.90M | 143.30M | 120.50M | -64.40M | 107.50M |
| Depreciation & amortization | 112.20M | 113.50M | 116.30M | 117.50M | 181.80M | 215.40M |
| Free cash flow | -13.40M | 34.60M | 79.20M | 48.90M | -168.00M | 9.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -2.70M | 0 | 0 | -100.00K | -6.20M | -2.00M |
| Ending cash balance | 549.20M | 586.50M | 714.10M | 2.21B | 1.01B | 880.80M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -3.81 | -39.37 | -83.27 | 1.38 | 11.35 | -5.45 | 5.79 | -3.28 |
| ROA %i | -0.75 | -6.85 | -8.94 | 0.10 | 1.11 | -0.62 | 0.65 | -0.34 |
| ROIC %i | 1.86 | -5.90 | -8.80 | 3.68 | 5.84 | 2.94 | 4.67 | 2.66 |
| 5-year avg ROE %i | 75.99 | 31.71 | -7.15 | -18.55 | -22.74 | -23.07 | -14.04 | 1.96 |
| EBIT margin %i | 1.41 | -4.83 | -8.45 | 3.81 | 4.15 | 2.91 | 4.06 | 3.47 |
| FCF / sales %i | 3.39 | 1.92 | 5.07 | 6.93 | 4.71 | 3.28 | 3.34 | 2.56 |
| Current ratioi | 1.50 | 1.81 | 1.92 | 1.78 | 1.66 | 1.67 | 1.63 | 2.95 |
| Quick ratioi | 1.06 | 1.31 | 1.38 | 1.24 | 1.11 | 1.11 | 1.07 | 1.17 |
| Debt / assetsi | 50.71 | 56.58 | 60.38 | 57.30 | 55.39 | 53.89 | 54.10 | 62.58 |
| LT debt / equityi | 248.45 | 379.40 | 954.31 | 695.85 | 467.45 | 470.72 | 473.85 | 646.75 |
| Interest coveragei | 0.47 | -1.45 | -1.87 | 1.01 | 1.38 | 0.88 | 1.34 | 1.01 |
| Revenue CAGR (3Y) %i | 23.04 | 18.27 | -9.07 | -10.82 | -3.87 | 8.87 | 5.90 | 0.20 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 81.03 | -- |
| FCF CAGR (3Y) %i | 10.19 | -11.35 | 15.28 | 13.19 | 29.68 | -5.86 | -16.99 | -18.27 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.40 | 6.38 | 6.01 | -3.28 | -12.11 | -14.98 |
| ROA %i | 0.39 | 0.77 | 0.75 | -0.34 | -1.55 | -2.00 |
| ROIC %i | 4.19 | 4.66 | 4.58 | 2.66 | 1.12 | 1.01 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.84 | 4.36 | 4.33 | 3.47 | 1.60 | 1.28 |
| FCF / sales %i | 3.73 | 2.77 | 2.92 | 2.56 | -- | -- |
| Current ratioi | 1.72 | 1.77 | 1.77 | 2.95 | 1.40 | 1.40 |
| Quick ratioi | 1.15 | 1.17 | 1.24 | 1.17 | 0.91 | 0.90 |
| Debt / assetsi | 53.13 | 51.78 | 50.95 | 62.58 | 47.39 | 47.05 |
| LT debt / equityi | 452.16 | 399.05 | 372.70 | 646.75 | 353.88 | 341.87 |
| Interest coveragei | 1.26 | 1.45 | 1.46 | 1.01 | 0.44 | 0.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Driveline is the largest reported line at 75.28% of revenue, across 3 reported segments.
- The next-largest line, Metal Forming, is a distant second at 29.15% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Driveline75.28%
Metal Forming29.15%
Quote time 2026-10-08 07:58:23 · For reference only, not investment advice and not tailored to your situation.